Be careful with these secretivestor8888 and mf both are losers

Ignore these two idiots , @ mf and secretinvestors8888 both are Top losers. Pasting every negative comments on medical counters.

secretinvestor8888 must be losing too much money in GENM, and Genting. Ask all of us to support his shares.

Secretinvestor. Who are you ! Ilkan bills ??? Must day I top up 10 mil on k plus

I do all my homework before I post my write-up here.
I hope to see PAT > 250 million.

Yes, We also Expected that much. > 250 million, Tan Sri Lim said that

The number of new case is keep increasing trend, record exceed 100k case every day. It is getting worsen rather than subside.

Even if vaccines found, how effective and how many time dose need to inject and can how long last the vaccines protection against virus. The virus unlike any other SAS or HINI, it spread for so rapidly, long and have infected million of people, the fatality rate of more than 5% and easy route of infection remain a risk of recurring pandemic through virus mutation.

Different vibrant of virus already found, type a, b, and c and it can continue evolve in future. The pathogenic of virus is prove capable of evolving. Global healthcare awareness is increasing, demanding personal protection become new normal in future not only confine into medical field, but more importantly, the increasing demand from non-medical field to avoid foreclosure risk if new case found.

First Epicenter of Covid-9
1. China
2. Italy

Current epicenter of Covid-9
1. US
2. Russia
2. Brazil

Next epicenter of covid-9
1. India
2. Pakistan
3. Bandgalesh
4. South African



South Africa's COVID-19 cases rise and president worries about Cape Town region

K One these coming Quarter company 100 % sure make money. $$$

This coming Quarter company 100 % sure make money.

Yes, Got licensed to distribute Worldwide. Very Good!

https://www.theedgemarkets.com/article/kone-secures-nasa-licence-manufacture-lowcost-ventilators-use-covid19-treatment

Yes. Got licensed to distributing Worldwide!

K-One granted non-exclusive license to distribute ventilator

https://www.theedgemarkets.com/article/kone-secures-nasa-licence-manufacture-lowcost-ventilators-use-covid19-treatment

Supermax Green now

Later afternnon careplus rm 2 plus

OYou throw, We COLLECT , We Buy .. pua Tua

Today limit up at 1.82 Tomorrow open price at 2.38

Those who don’t believe regret later

Limit up today , Adventa, HLT, next careplus ..

Buy Buy Buy.. tomorrow 2.10 start those who buy today tomorrow big win

BUY before too late
Last call

Now careplus 1.79 another 0.04 cents to reach 1.82 limit up. once limit up. get another bonus. buy buy buy

Limit up today but buy buy

Buy buy buy

Now still cheap
Buy Buy buy

Ya, limit up today

United States - 1,756,170 cases, 103,153 deaths

Brazil - 465,166 cases, 27,878 deaths

Russia - 396,575 cases, 4,555 deaths

United Kingdom - 274,219 cases, 38,458 deaths

Spain - 239,228 cases, 27,125 deaths

Italy - 232,664 cases, 33,340 deaths

France - 186,924 cases, 28,717 deaths

Germany - 183,125 cases, 8,527 deaths

India - 181,401 cases, 5,170 deaths

Turkey - 162,120 cases, 4,489 deaths

Iran - 148,950 cases, 7,734 deaths

Peru - 148,285 cases, 4,230 deaths

Chile - 94,858 cases, 997 deaths

Canada - 90,930 cases, 7,065 deaths

Mexico - 84,627 cases, 9,415 deaths

China - 84,127 cases, 4,638 deaths

Saudi Arabia - 83,384 cases, 480 deaths

Comfort sudah sampai from 1.00 to 3.62
Ruberex pun sudah sampai 1.00 to 3.56
Tapi Carepls baru nak goreng goreng juga sampai 3.000
hahaha

Massive earnings in coming quarter will forecast out the window.we raise our FY20-22E EPS by 37%/180%|8%. 0ur new TP is MYR 20.00 ( + 83%). TOPGLOVE

Maybank TP. Topglove

Massive earnings in coming quarter will forecast out the window.we raise our FY20-22E EPS by 37%/180%|8%. 0ur new TP is MYR 20.00 ( + 83%). TOPGLOVE

Maybank TP. Topglove

Maybank TP for Topglove RM 20

https://www.nst.com.my/business/2020/05/595672/supermax-buys-klang-land-plant-no-16

Outlook. Plant 12 consists of Block A and Block B, each consisting of 8 double former lines with 2.2b pieces each (total 4.4b pieces). As of now, for Block A, its remaining 3 lines started commissioning in end March 2020 on top of the 5 lines already in commercial production. For Block B, all 8 lines are expected to be fully commissioned by 2H 2020. Upon full commercial production by 2H 2020, installed capacity will rise 13.4% to 26.2b pieces per annum.

Raised FY20E/FY211E net profit by 6%/16% after raising our pre-tax margin from 13%/14% to 16%/18%.

Undemanding FY21E PER valuation of 18x compared to expected earnings growth of 68%. Correspondingly, our TP is raised form RM6.60 to RM7.60 based on unchanged 26x CY21 revised EPS of 25.4 sen (at slightly above +2.0SD above the 5-year historical forward mean). We like Supermax because: (i) the stock is trading at an undemanding 18x FY21E EPS compared to expected earnings growth of 68%, and (ii) of its OBM model, where it can extract higher margin from distributor prices, compared to the OEM model at lower factory prices. Reiterate Outperform. Key risk to our call is longer-than-expected commercial operations of new plants.

Source: Kenanga Research - 22 May 2020

We are excited with Supermax prospects over the next few quarters following a 3QFY20 post result briefing. Specifically, Supermax is expected to gain from higher margins from both its gloves manufacturing and distribution channels due to abnormal demand and acute supply tightness. We expect higher margins going forward due to higher product mix skewed towards OBM distribution which accounts for 95% compared to 70% pre Covid-19 which we believe had caught us as well as market by surprise. Hence, we raised our FY20E/FY21E net profit by 6%/16%, to account for higher margins. TP is raised from RM6.60 to RM7.60 based on unchanged 26x CY21E EPS. Reiterate OP.

Dual-stream incomes from manufacturing and distribution. Specifically, Supermax is expected to gain from higher margins from both its gloves manufacturing and distribution due to abnormal demand and acute supply tightness. We expect higher margins going forward due to higher product mix skewed towards OBM distribution which accounts for 95% compared to 70% pre Covid-19 which we believe had caught us as well as the market by surprise at a time when of tight supply due to aggressive stockpiling of critical medical supplies including gloves. Typically, manufacturing OEM pre-tax margin ranges between 12% to 15% compared to Own Brand Manufacturing (OBM) pre-tax margin of 15% to 20%. In terms of demand, Supermax is getting enquiries from foreign government agencies, non-government organisations, retail and restaurants chains. Amplifying the pent-up demand, buyers are paying between 30% to 50% deposits in advance to secure glove supply and timely delivery. The delivery lead time has now risen from 45 to 60 days pre Covid-19 to 10 to 12 months currently. Case in point is Supermax’s overseas distribution centres which are experiencing fast inventory depletion from usual 4 months to within 6 weeks. Supermax expects the heightened demand to continue for the next 1 to 1.5 years. All in, we are bullish on higher-than-expected margins since ASP has been moving upwards week-on-week. As demand pick up, containers are shipping at prices higher than previous months.

Remember KYY statement;


People always follow the crowd, like a herd of saheep. It is called a herd mentality as demonstrat

As I said before, due to Covid 19 pandemic, the demand for gloves far exceeds supply. As a result, the glove price continues to go up higher and higher and all glove makers are making more and more profit which is being reflected on their share prices. This situation will continue until Covid 19 in under control. Many scientists predicted that Covid 19 pandemic will not be under control for at least another year until a vaccine is discovered and approved by FDA of USA.

,Read Properly,

the vaccine is still being tested. Will try phase 3 moderna vaccine only In July.


The company now says it will begin the Phase 3 trial of the vaccine in July. It has previously said it hoped to have doses ready in July.



https://www.barrons.com/amp/articles/moderna-coronavirus-vaccine-shows-postive-results-in-early-human-tests-what-comes-next-51589801723

Long term RM6. Vaccine Will be tested only on July. “Not confirmed vaccine “ yet.

Brent oil Up 1.12 %

Brent oil up 1.78% now

India got more than 100,500 cases people infected corona virus. World convicted cases surge !! Vivid 19

Pls don’t look down on comfort.


Beside, harta, top glove, superxm and kossan.


Comfort!!!

Guys, Read Properly,

the vaccine is still being tested. Will try phase 3 moderna vaccine only In July.


The company now says it will begin the Phase 3 trial of the vaccine in July. It has previously said it hoped to have doses ready in July.



https://www.barrons.com/amp/articles/moderna-coronavirus-vaccine-shows-postive-results-in-early-human-tests-what-comes-next-51589801723

Dow jone up 800 points, take cheap comfort to high

Comfort 2.25 Supermax 4.40.
Kossan. 7.70
Top glove 10.520


Comfort still very cheap if compared to glove counters

Anyone know when is comfort result out for this quarter ?

Supermax is so high. Comfort apa jadi ?

SInce KYY is so confident in comfort, he has to make it. Real. Real like a Genuine Comfortable to target!

Hey Guys, After read you guys discussion, and debation. In the mean time, apparently comfort Berhad is still uptrending Stock. Many oppoutunities up forward almost for time being, overall move higher in price, created by higher swing demand.

Comfort’s Technical indicators analyzing uptrends.

Next week COMFORT counter all the way up!!! Looking Height and Bright Future!!